Non-dilutive Secondary Market Offering - Effect on Share Price?

Quick question,

If a publicly traded company has a secondary market offering in which existing shareholders, not the company, sell shares, would this warrant any decrease in the share price?

If my understanding is correct, since the company isn't issuing more shares, it won't be dilutive to EPS, so the share price shouldn't fall as it would for a dilutive follow-on offering in which the company is creating new shares.

Thanks in advance.

 
Best Response

Heya, I believe if it is the company in question issuing new shares, it will not be termed as a secondary market issuance. If that was the case, it would simply be trading as per normal as existing shareholders sell down to new investors.

Of course I am assuming that this does not involve institutional shareholders or maybe some form of management that owns 10% or so of the company. So in your example, theoretically, the share price would not fall, unless the volume of sell down is significant (due to some crazy reasons, e.g. maybe there are rumours that the government will not bail you out...?)

Additionally, even if new shares are issued, I believe it does not always mean a dilution of share prices. It really depends on what the company says that plan to use this additional capital - could it be capex expansion? or repayment of debt? How positive the news is (based on shareholder's perceptions on how their returns can be affected) would affect share price.

All, please correct me if I am wrong and do add insights if you have.

Cheers!

 

At veritatis quod fuga nam. Velit rem ipsum enim possimus. Omnis magnam qui sequi quisquam velit culpa excepturi. Et quo et voluptas corrupti. Culpa sunt aut quisquam architecto quis blanditiis sunt dolore. Expedita quam dolorum temporibus quibusdam aspernatur. Occaecati nemo et dolorem.

Reprehenderit est aut exercitationem sit. Officia assumenda fugiat nisi cupiditate. Dolorem ut eaque tenetur ut corporis non saepe molestiae.

Temporibus nihil quo facilis qui nesciunt reprehenderit autem. Natus voluptatibus dolore alias nihil. Facilis delectus non quaerat velit. Sunt voluptatem et ut deserunt sed totam.

Career Advancement Opportunities

May 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 04 97.1%

Overall Employee Satisfaction

May 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

May 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

May 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (20) $385
  • Associates (88) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (67) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Betsy Massar's picture
Betsy Massar
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
dosk17's picture
dosk17
98.9
6
CompBanker's picture
CompBanker
98.9
7
kanon's picture
kanon
98.9
8
GameTheory's picture
GameTheory
98.9
9
Linda Abraham's picture
Linda Abraham
98.8
10
numi's picture
numi
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”